Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
ICIs can ameliorate OS and PFS of cancer patients in groups below 65 years and 65-75 years.
Conversely, patients in the group of 75 years or above failed to acquire benefit from ICIs for both OS
Subgroup analysis was performed based on the class of ICIs, type of ICIs, type of cancer, line of treatment, blind method, and type of non-small-cell lung cancer…